How Much Methylfolate Should I Take During Pregnancy?

Most pregnant women need between 400 and 800 micrograms of folate daily, and that target holds whether you take it as folic acid or as methylfolate (also called L-methylfolate or 5-MTHF). The difference between the two forms is how your body processes them, not how much you need. For women at higher risk of neural tube defects, that dose can climb to 4 or even 5 milligrams per day under medical supervision. But the answer is not quite as tidy as a single number, because methylfolate has some quirks around labeling, absorption, and who benefits most from choosing it over standard folic acid.

The Standard Recommendation

Global guidelines converge on a daily folate dose of 0.4 to 0.8 mg (400 to 800 mcg) for women who are pregnant or planning to become pregnant, primarily to prevent neural tube defects like spina bifida and anencephaly.¹ That range applies to the general population of childbearing-age women with no additional risk factors. Most prenatal vitamins contain somewhere in this window, though the form of folate they use varies. Some contain synthetic folic acid, others contain methylfolate, and a growing number contain a combination of both.

If you pick up a prenatal supplement that lists methylfolate as its folate source, the amount on the label should fall in the same 400–800 mcg range for a standard-risk pregnancy. There is no evidence that you need a wildly different amount of methylfolate compared to folic acid to achieve protective folate levels. The case for methylfolate is less about changing the dose and more about whether your body can effectively use folic acid in the first place.

Why Some Women Choose Methylfolate Over Folic Acid

Folic acid is synthetic. Your body does not use it directly. It has to convert folic acid through several steps, and the final conversion relies on an enzyme called MTHFR. The end product of that chain is L-methylfolate, the form your cells actually put to work. Methylfolate supplements skip the conversion process entirely and deliver the end product straight into your bloodstream.²

For most people, this distinction does not matter much. The conversion works fine, and folic acid does its job. But a significant share of the population carries genetic variants in the MTHFR gene that slow down or partially cripple that final conversion step. These variants are common enough that some researchers have argued supplementing with methylfolate may be the safest way to ensure all pregnant women reach adequate folate levels, regardless of their genetic makeup.² In a randomized trial of women of childbearing age, L-methylfolate raised red blood cell folate levels more effectively than folic acid did.³

MTHFR Variants and What They Mean for Your Dose

MTHFR polymorphisms are among the most common genetic variants in humans. The two most studied are C677T and A1298C. Carrying one or two copies of C677T reduces your enzyme activity, meaning you convert less folic acid into usable methylfolate. People who are homozygous for C677T (meaning they carry two copies) have the most pronounced reduction in enzyme activity. MTHFR genetics and vitamin B12 status are considered critical modifiers of how your body handles folate during pregnancy.⁴

If you know you carry an MTHFR variant, methylfolate sidesteps the problem. You do not need to worry about whether your enzyme is keeping up, because the supplement is already in the form your body uses. The dose itself does not necessarily need to increase just because you have an MTHFR variant, as long as you are taking the methylfolate form. The standard 400–800 mcg range still applies for most women. The exception is when MTHFR status is combined with other risk factors, which pushes you into a higher-dose category.

One thing worth knowing: excessive folic acid intake in women with MTHFR variants can lead to a buildup of unmetabolized folic acid, which has been linked to masking vitamin B12 deficiency and, in some research, to cognitive and psychiatric concerns.⁵ Methylfolate avoids this particular problem, which is part of its appeal for women with these variants.

When You Need a Higher Dose

The 400–800 mcg recommendation is for women at standard risk. Several categories of women are advised to take substantially more, typically 4 to 5 mg per day. This includes women who have had a previous pregnancy affected by a neural tube defect, women with diabetes, women with a BMI of 30 or above, and women taking certain medications that interfere with folate metabolism.⁶ The high-dose recommendation for women with a personal or family history of neural tube defects is consistent across international guidelines.⁷

Some of these high-dose studies were conducted using folic acid rather than methylfolate. A small study of women with MTHFR mutations and recurrent pregnancy loss used methylfolate at 5 mg per day alongside vitamin B6 and weekly vitamin B12 injections. Their homocysteine levels dropped sharply, and seven of the women became pregnant and delivered successfully during the year of follow-up.⁸ That was a small case series, not a large trial, so the numbers should be read cautiously. But it illustrates that high-dose methylfolate is used in clinical practice for high-risk populations.

If you fall into a high-risk category, your dose should be determined by your doctor. Self-prescribing 4–5 mg of any folate form without medical guidance is not advisable, particularly because high doses require monitoring for other nutritional interactions, especially B12.

The Unmetabolized Folic Acid Problem

When you take synthetic folic acid, your body’s conversion machinery has a limited capacity. The enzyme that handles the first step (dihydrofolate reductase) can be overwhelmed by high or even moderate doses of folic acid.⁹ When that happens, unmetabolized folic acid (UMFA) enters the bloodstream. This is not the same as having too much folate; it is a specific issue with unprocessed folic acid floating around in your system.

A randomized trial comparing prenatal vitamins containing folic acid versus methylfolate found a striking difference: at 24 weeks, about a third of women in the folic acid group had detectable UMFA in their blood, compared to only 7% in the methylfolate group. The folic acid group also had higher UMFA concentrations in both maternal blood and placental tissue.¹⁰ The methylfolate group was not entirely free of UMFA either (likely because some folic acid still enters the body through fortified foods), but the reduction was significant.

Whether UMFA causes real harm is still debated. Some researchers have raised concerns about immune dysfunction and links to certain cancers.¹¹ The European Food Safety Authority reviewed the evidence and found it insufficient to confirm a causal relationship between dietary folate intake and cancer or cognitive decline.¹² So the concern exists but is not settled. For women who want to minimize UMFA exposure during pregnancy, particularly those already consuming fortified foods and taking a prenatal vitamin, methylfolate is the more straightforward option.

Upper Limits and Safety

The tolerable upper intake level for folic acid in adults, including pregnant women, is 1,000 mcg (1 mg) per day. This was set by European and North American food safety authorities, and it is based on the risk that high folic acid intake could mask the blood-related symptoms of vitamin B12 deficiency, allowing nerve damage to progress unnoticed.¹²

Here is where things get a bit tangled. The European Food Safety Authority’s 2023 opinion stated that this upper limit applies not just to folic acid but also to the authorized forms of methylfolate (calcium L-methylfolate and 5-MTHF glucosamine salt) under their approved conditions of use.¹² Many practitioners had assumed that methylfolate would not carry the same masking risk, because the B12-masking concern was specifically about unmetabolized folic acid. But the regulatory position, for now, groups them together. In practice, the high-dose clinical use of methylfolate at 4–5 mg per day for high-risk women exceeds this upper limit and is done under medical supervision precisely because it requires monitoring.

If you are taking a standard prenatal vitamin with 400–1,000 mcg of methylfolate, you are within the accepted safety range. If you are stacking additional folate supplements on top of a prenatal vitamin, or eating a lot of fortified foods, you could be exceeding the upper limit without realizing it.

The Confusing World of Folate Labels

Reading a prenatal supplement label for its folate content is surprisingly complicated. Newer labeling regulations require folate to be listed in micrograms of dietary folate equivalents (DFE) rather than just micrograms of the substance.¹³ The DFE system accounts for the fact that synthetic folic acid is more bioavailable than natural food folate, using a conversion factor of 1.7. So 400 mcg of folic acid becomes 680 mcg DFE on the label.

Methylfolate gets caught up in this system. North American manufacturers are permitted to apply the same 1.7 conversion factor to methylfolate, even though it is not entirely clear whether methylfolate has the same enhanced bioavailability that folic acid does compared to food folate.¹⁴ The upshot is that a label reading “1,360 mcg DFE (from 800 mcg L-methylfolate)” is telling you the actual methylfolate content is 800 mcg, inflated to 1,360 by the conversion factor. What matters for your dose is the actual amount of methylfolate, not the DFE figure. When your doctor says “take 800 mcg of folate,” they typically mean 800 mcg of the active compound, not 800 mcg DFE.

Supplement forms also vary. The two most common are calcium L-methylfolate (sold under the brand name Metafolin) and 5-MTHF glucosamine salt. The European Food Safety Authority considers the difference between these two salt forms to be within the margin of error for bioavailability.¹⁵ In other words, they are functionally interchangeable. Pick based on availability and price, not because one is supposedly superior.

Medication Interactions That Change the Equation

Certain medications interfere with folate metabolism in ways that can change how much you need. The most studied category is antiepileptic drugs, particularly valproate. Women taking valproate or other antiseizure medications are at elevated risk for neural tube defects in their offspring, and some experts have argued that the standard 400 mcg dose is not enough to protect against drug-induced folate disruption. The recommendation in this group can go up to 5 mg daily, with the additional caveat that supplementary B12 may also be warranted.¹⁶

The optimal folate dose for women with epilepsy is influenced by a tangle of factors: the specific antiseizure medication, dietary intake, food fortification in the country they live in, genetic background, and comorbidities like obesity or anemia.¹⁷ There is no single dose that fits all women on antiepileptic drugs, which is why expert consensus still calls for individualized dosing in this group. Methotrexate and certain other folate-antagonist drugs present similar challenges, though methotrexate is typically discontinued before pregnancy attempts.

If you take any medication that interacts with folate, methylfolate may have a theoretical advantage because it bypasses the metabolic steps these drugs disrupt. But the clinical evidence for methylfolate specifically in medication-interaction scenarios is limited. Most of the high-dose studies in these populations used folic acid. Discuss both the dose and the form with the prescribing physician.

Methylfolate and Recurrent Pregnancy Loss

There is growing clinical interest in methylfolate for women who have experienced repeated miscarriages, particularly those with MTHFR variants. In one comparative study, women with MTHFR mutations and recurrent pregnancy loss were split into two groups: one received standard folic acid, the other received L-methylfolate. In the folic acid group, more than half of pregnancies ended in miscarriage, compared to only about one in six in the methylfolate group. Full-term deliveries were also substantially higher in the methylfolate group.¹⁸

These are encouraging results, but the studies in this area tend to be small. The evidence is not yet strong enough to make a blanket recommendation that all women with recurrent loss should switch to methylfolate. What the data does suggest is that for women who carry MTHFR variants and have a history of loss, the conversation with their provider about folate form is worth having. Some fertility specialists already default to methylfolate in this population as a precautionary measure.

The Role of Vitamin B12

Folate does not work in isolation. Vitamin B12 is a partner in the same metabolic pathways, and being low in B12 while taking high-dose folate of any kind can cause problems. The classic concern is that folate supplementation can correct the blood abnormalities caused by B12 deficiency (a type of anemia) while leaving the neurological damage from B12 deficiency to progress silently. This is the original reason food safety authorities set an upper limit on folic acid.

During pregnancy, B12 status takes on additional importance because both nutrients act as modifiers of folate metabolism and pregnancy outcomes.⁴ If you are taking methylfolate, especially at higher doses, making sure your B12 intake is adequate is not optional. Most prenatal vitamins include B12, but the amount varies. Women who follow a vegan or vegetarian diet, or who have absorption issues (from conditions like celiac disease or prior gastric surgery), are at particular risk for B12 insufficiency and should have their levels checked.

When to Start and How Long to Continue

Neural tube closure happens in the first 28 days after conception, often before a woman knows she is pregnant. This is why every major guideline recommends starting folate supplementation before you conceive, ideally at least one month ahead and preferably longer. Evidence on timing suggests that beginning folate supplementation well before conception is associated with measurable changes in cord blood DNA methylation patterns, reflecting how early and thoroughly the nutrient integrates into fetal development. In one study, starting folic acid supplementation more than six months before conception was associated with higher methylation at certain genes compared to starting three to six months before.¹⁹

After the first trimester, the neural tube has long since closed, but folate continues to play roles in DNA synthesis, placental growth, and red blood cell production. Most guidelines recommend continuing supplementation throughout pregnancy. The same study found that women who took folic acid throughout the entire pregnancy had different methylation patterns in their babies’ cord blood compared to women who stopped in the second trimester.¹⁹ What those epigenetic differences mean for a child’s long-term health is still being studied, but they reinforce that folate is doing things beyond neural tube protection.

Methylfolate and Fetal Brain Development

One area where methylfolate may have a distinct advantage over folic acid involves the developing brain. Methylfolate crosses the blood-brain barrier efficiently and supports fetal and neonatal brain development in ways that have attracted research attention in the context of neurodevelopmental conditions.²⁰ Some researchers have proposed that supplementing with reduced folate forms early in development, including during fetal life, could help reduce the severity of autism spectrum symptoms by supporting the brain during critical neurodevelopmental windows.²¹

This is preliminary territory. No large randomized trial has demonstrated that methylfolate prevents autism or other neurodevelopmental conditions. The hypothesis is biologically plausible and actively being explored, but it should not be the primary reason you choose methylfolate over folic acid. The primary reason remains ensuring adequate folate levels for neural tube defect prevention and overall healthy fetal development. The potential brain-development advantage is a bonus that the science has not yet confirmed.

How Folate Intake Shapes the Epigenome

Folate is a methyl donor, meaning it supplies the chemical groups your cells use to tag DNA in ways that turn genes on or off. This process, called DNA methylation, is especially active during pregnancy as the fetal genome is being set up. Animal and human studies have shown that maternal folate intake during pregnancy influences the offspring’s methylation patterns, and these patterns can persist beyond birth.²²

The practical implication is that folate is not just preventing a specific defect. It is participating in a broader process of gene regulation in your developing baby. Both too little and potentially too much folate could shift these patterns in ways researchers are still working to understand. This is another reason the “more is better” approach to supplementation is not necessarily sound, and why staying within recommended ranges matters even when the nutrient itself is essential.